Immuneering (IMRX) vs Sol-Gel Technologies (SLGL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Sol-Gel Technologies (SLGL) has outperformed Immuneering (IMRX) over the past year, gaining 75.5% versus a loss of 36.8%. Over five years, SLGL leads with a -22.8% price change compared with -84.5% for IMRX. Immuneering is the larger company by market cap ($249.7 million vs $235.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | IMRX | SLGL |
|---|---|---|
| Share price | $3.86 | $71.95 |
| Market cap | $249.73M | $235.55M |
| 1-day change | +0.78% | -4.88% |
| YTD return | -41.34% | +70.73% |
| 1-year return | -36.82% | +75.52% |
| 5-year return | -84.47% | -22.85% |
| EPS (TTM) | $-0.94 | $-5.34 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.48 | $97.97 |
| 52-week low | $3.74 | $28.81 |
| Distance from 52-week high | -54.48% | -26.56% |
| Average volume | 693.70K | 55.68K |
| Shares outstanding | 64.70M | 3.27M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- SLGL has outperformed IMRX by 112.3 percentage points over the past year.
IMRX vs SLGL FAQ
Which is bigger, Immuneering or Sol-Gel Technologies?
Immuneering (IMRX) is larger, with a market capitalization of $249.73M compared with $235.55M for Sol-Gel Technologies (SLGL).
Which stock has performed better over the past year, IMRX or SLGL?
SLGL returned +75.52% over the past 12 months, compared with -36.82% for IMRX (price return, excluding dividends). Past performance does not predict future results.
Are Immuneering and Sol-Gel Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.